‘A’ for access: Health leaders warn that despite reform, uncertainty abounds
Features, Health Care & Life Science, Tri-County EconomyAs it nears the takeoff point, Obamacare gets an “A” for increased access but just average grades for implementation, so far. That was the consensus view among a panel of three regional health care experts at the kickoff on Sept. 17 for California Lutheran University’s Corporate Leader’s breakfast series. All of the panelists gave the Read More →
Trojan-Bruin rivalry likely to extend with health care consolidation
Columns, OpinionIt’s true in football. And in life. And it quite likely is going to be true in health care. Which is to say that human existence in Southern California really boils down to a single question — are you a Bruin or a Trojan? The UCLA Bruins and the University of Southern California Trojans have Read More →
Fed chair needs chemistry, consensus building and communications skills
Columns, OpinionI’m writing about G. William Miller, whose term at the head of the nation’s central bank in the late 1970s was short and tumultuous.
Ventura County sheriff takes aim at rougue doctors, pharmacists
Columns, OpinionSuddenly, the buzz among my peers over dinner and drinks has turned to the television show “Breaking Bad.” Whether you’re a fan of the show on cable, on DVD or perhaps a casual channel surfer like me, there is a morbid fascination with the tale of a teacher-turned-meth-mogul and the characters around him. Which brings Read More →
New book looks at J.D. Power’s impact on auto industry
Latest newsWhen the history of the automotive industry in the 21st Century is written, it will be hard to ignore the long-term influence of J.D. “Dave” Power III and the rankings produced by Westlake Village-based J.D. Power & Associates. Power’ pioneering efforts to put the consumer in the driver’s seat by measuring customer satisfaction with new Read More →
The top five financial truths in blockbuster Amgen-Onyx deal
Columns, OpinionFor sheer size and scale, Amgen’s $10.4 billion purchase of South San Francisco-based cancer drug maker Onyx Pharmaceuticals dwarfs any recent deal in the Tri-Counties. For size, let’s remember that Dole Food Co. is selling its entire self for about $1.3 billion and that Santa Barbara Bank & Trust parent Pacific Capital Bancorp, previously the Read More →
The Golden State needs to stop scaring away its manufacturers
Columns, OpinionWhat California doesn’t have is a government that provides a clear set of rules for manufacturers or a playing field that’s remotely level with other states.
